Rucaparib Recruiting Phase 2 Trials for metastatic Endometrial cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03617679Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer